However, a study of IL-33 levels in patients with acute coronary syndrome (ACS) showed that IL-33 levels gradually decreased after ACS in patients with ST-segment elevation myocardial infarction (STEMI), in contrast with sST2, which has constant levels over the same period. This evidence concerns the gene IL33 and acute coronary syndrome.